Kallyope
Operator of a biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis.
Drug Discovery
📍 New York, NY
Founded 2015
Current Valuation
$1.1B
as of 2022-Q1
UNICORN
Operator of a biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis.
Company Profile
Last Round
Series D — $236M (Jan 2022)
Fundraising Status
Series D · $236M · 4y 5mo ago
privateTotal raised $479M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series D | $236M | Jan 2022 | — | $1.1B |
BiotechnologyHealth CareMedicalPharmaceutical
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.